Replies to post #353496 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Revenue materiality - this is a super tiny ANDA with a total market of only $5M with several competitors. I can see them not doing a PR for this one. Not exactly a reason to celebrate, but little Loxapine will being in more revenue than the millions and millions spent on SequestOx and opioid line.

[alexander77]

I agree with you.